Papers

3

Total Citations

195

H-Index

3

About

Vincent Hupertan is a French urological surgeon whose research has advanced the surgical management of renal cell carcinoma and prostate cancer. His work centers on comparing oncologic and functional outcomes across open, laparoscopic, and robot-assisted surgical approaches, helping to define the modern role of minimally invasive techniques. His most influential study, a prospective comparison of elective partial nephrectomy for renal cell carcinoma, demonstrated that robot-assisted surgery achieves equivalent pathologic and surgical outcomes to open surgery while reducing morbidity—a finding that has shaped current clinical practice with 108 citations. He also contributed a landmark comparison of mid-term carcinologic control after radical prostatectomy, showing that robot-assisted and laparoscopic approaches provide oncologic results comparable to open surgery for localized prostate cancer (82 citations). Additionally, his analysis of evolving renal surgery practices following 2010 AFU guidelines documented the rapid adoption of nephron-sparing techniques across France. Through these contributions, Hupertan has provided critical evidence supporting the safety and efficacy of minimally invasive urologic oncology, influencing surgical decision-making worldwide.

Research Focus

Key Achievements

3
H-Index
3
Papers
195
Total Citations
65
Avg Citations/Paper
🏆 Most Cited Paper
A prospective comparison of the pathologic and surgical outcomes obtained after elective treatment of renal cell carcinoma by open or robot-assisted partial nephrectomy
108 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Pitié-Salpêtrière Hospital, Sorbonne Université, Université Paris Cité

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago